IL238053A0 - An immunogenic composition containing one or more conjugates of capsular saccharide of Streptococcus pneumoniae and a protein component containing protein e and/or pila of Haemophilus influenzae - Google Patents

An immunogenic composition containing one or more conjugates of capsular saccharide of Streptococcus pneumoniae and a protein component containing protein e and/or pila of Haemophilus influenzae

Info

Publication number: IL238053A0
Authority: IL; Israel
Prior art keywords: protein; fromhaemophilus; pila; influenzae; immunogenic composition
Prior art date: 2012-10-17

Application number

IL238053A

Other languages

English (en)

Hebrew (he)

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-17

Filing date

2015-03-31

Publication date

2015-05-31

2012-10-17 Priority claimed from GBGB1218660.7A external-priority patent/GB201218660D0/en

2013-03-14 Priority claimed from US13/826,932 external-priority patent/US20140193451A1/en

2013-03-14 Priority claimed from US13/827,203 external-priority patent/US20140105927A1/en

2015-03-31 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2015-05-31 Publication of IL238053A0 publication Critical patent/IL238053A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
AIDS & HIV (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)

IL238053A 2012-10-17 2015-03-31 An immunogenic composition containing one or more conjugates of capsular saccharide of Streptococcus pneumoniae and a protein component containing protein e and/or pila of Haemophilus influenzae IL238053A0 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US201261714956P	2012-10-17	2012-10-17
US201261714942P	2012-10-17	2012-10-17
GBGB1218660.7A GB201218660D0 (en)	2012-10-17	2012-10-17	Immunogenic composition
US13/826,696 US9561268B2 (en)	2012-10-17	2013-03-14	Immunogenic composition
US13/826,932 US20140193451A1 (en)	2012-10-17	2013-03-14	Immunogenic composition
US13/827,203 US20140105927A1 (en)	2012-10-17	2013-03-14	Immunogenic composition
PCT/EP2013/071472 WO2014060383A1 (en)	2012-10-17	2013-10-15	Immunogenic composition comprising 1 or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila fromhaemophilus influenzae.

Publications (1)

Publication Number	Publication Date
IL238053A0 true IL238053A0 (en)	2015-05-31

Family

ID=53008966

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL238053A IL238053A0 (en)	2012-10-17	2015-03-31	An immunogenic composition containing one or more conjugates of capsular saccharide of Streptococcus pneumoniae and a protein component containing protein e and/or pila of Haemophilus influenzae
IL238079A IL238079A0 (en)	2012-10-17	2015-04-01	Immunogenic preparation

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL238079A IL238079A0 (en)	2012-10-17	2015-04-01	Immunogenic preparation

Country Status (13)

Country	Link
EP (3)	EP2908854A2 (2)
JP (3)	JP6412500B2 (2)
KR (2)	KR20150072444A (2)
CN (2)	CN104968366B (2)
AU (2)	AU2013331781A1 (2)
BR (3)	BR112015008418A2 (2)
CA (3)	CA2888321A1 (2)
EA (2)	EA201590491A1 (2)
ES (1)	ES2640320T3 (2)
IL (2)	IL238053A0 (2)
MX (2)	MX2015005002A (2)
SG (2)	SG11201502634TA (2)
WO (3)	WO2014060385A1 (2)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201218660D0 (en)	2012-10-17	2012-11-28	Glaxosmithkline Biolog Sa	Immunogenic composition
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN104306965B (zh) *	2014-10-31	2017-05-10	康希诺生物股份公司	预防肺炎链球菌感染性疾病的免疫原性组合物及制备方法
KR102225282B1 (ko) *	2015-07-21	2021-03-10	화이자 인코포레이티드	접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
GB201518684D0 (en) *	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
GB201603029D0 (en) *	2016-02-22	2016-04-06	Glaxosmithkline Biolog Sa	Vaccine
CN106432512B (zh) *	2016-09-30	2022-03-01	康希诺生物股份公司	一种增强多糖抗原免疫原性蛋白载体及其制备方法与应用
KR102905809B1 (ko) *	2018-01-19	2025-12-30	오비아이 파머 인코퍼레이티드	Crm197 단백질 발현
CN110540597B (zh) *	2018-12-20	2021-04-30	湖北工业大学	基于流感嗜血杆菌表面蛋白的乳胶微球免疫层析试纸的制备方法
MY207887A (en) *	2020-05-01	2025-03-26	Sinocelltech Ltd	Method for improving immunogenicity of protein/peptide antigen
KR20220142219A (ko) *	2021-04-14	2022-10-21	한국생명공학연구원	장내 미생물에서 단백질 분비를 유도하는 신호서열
EP4169513A1 (en)	2021-10-19	2023-04-26	GlaxoSmithKline Biologicals S.A.	Adjuvant composition comprising sting agonists
CN117512031B (zh) *	2023-10-16	2024-06-25	江苏金迪克生物技术股份有限公司	一种肺炎球菌荚膜多糖的纯化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE459373T1 (de) *	1999-03-19	2010-03-15	Glaxosmithkline Biolog Sa	Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
CZ20024224A3 (cs) *	2000-06-29	2003-05-14	Glaxosmithkline Biologicals S. A.	Farmaceutický prostředek
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
GB0022742D0 (en) *	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
GB0130215D0 (en) *	2001-12-18	2002-02-06	Glaxosmithkline Biolog Sa	Vaccine
ATE557033T1 (de) *	2003-12-23	2012-05-15	Nationwide Children S Hospital Inc	Pili von haemophilus influenzae typ iv
ATE488526T1 (de) *	2005-07-08	2010-12-15	Nationwide Childrens Hospital	Chimärer impfstoff für haemophilus influenzae- induzierte infektion
MY150105A (en) *	2006-01-17	2013-11-29	Forsgren Arne	A novel surface exposed haemophilus influenzae protein (protein e; pe)
CA2690708A1 (en) *	2007-06-26	2008-12-31	Glaxosmithkline Biologicals S.A.	Vaccine
MX2011006922A (es) *	2008-12-24	2012-06-12	Netherlands Vaccine Inst	Polipeptidos de neumolisina (ply) modificada a partir de streptococcus pneumonia.
WO2011027257A2 (en) *	2009-09-03	2011-03-10	Pfizer Vaccines Llc	Pcsk9 vaccine
AU2010335970B2 (en) *	2009-12-22	2016-11-03	Sanofi Pasteur Limited	Immunogenic compositions
MX2013006255A (es) *	2010-12-03	2015-08-05	Sanofi Pasteur Ltd	Composicion para inmunizacion contra streptococcus pneumoniae.
BR112013024322B1 (pt) *	2011-03-22	2020-04-22	Serum Inst India Ltd	processo para preparação de polissacarídeos
TW201302779A (zh) *	2011-04-13	2013-01-16	Glaxosmithkline Biolog Sa	融合蛋白質及組合疫苗
CN103533953A (zh) *	2011-05-17	2014-01-22	葛兰素史密丝克莱恩生物有限公司	针对肺炎链球菌的疫苗

2013
- 2013-10-15 EA EA201590491A patent/EA201590491A1/ru unknown
- 2013-10-15 CA CA2888321A patent/CA2888321A1/en not_active Abandoned
- 2013-10-15 BR BR112015008418A patent/BR112015008418A2/pt not_active IP Right Cessation
- 2013-10-15 ES ES13779190.1T patent/ES2640320T3/es active Active
- 2013-10-15 CN CN201380066162.9A patent/CN104968366B/zh active Active
- 2013-10-15 BR BR112015008419-2A patent/BR112015008419B1/pt active IP Right Grant
- 2013-10-15 EP EP13776808.1A patent/EP2908854A2/en not_active Ceased
- 2013-10-15 CA CA2888300A patent/CA2888300A1/en not_active Abandoned
- 2013-10-15 BR BR112015008417A patent/BR112015008417A8/pt not_active Application Discontinuation
- 2013-10-15 MX MX2015005002A patent/MX2015005002A/es unknown
- 2013-10-15 SG SG11201502634TA patent/SG11201502634TA/en unknown
- 2013-10-15 WO PCT/EP2013/071477 patent/WO2014060385A1/en not_active Ceased
- 2013-10-15 CN CN201380066113.5A patent/CN104853768B/zh not_active Expired - Fee Related
- 2013-10-15 JP JP2015537218A patent/JP6412500B2/ja not_active Expired - Fee Related
- 2013-10-15 AU AU2013331781A patent/AU2013331781A1/en not_active Abandoned
- 2013-10-15 CA CA2888310A patent/CA2888310C/en active Active
- 2013-10-15 MX MX2015004949A patent/MX365842B/es active IP Right Grant
- 2013-10-15 SG SG11201502635SA patent/SG11201502635SA/en unknown
- 2013-10-15 KR KR1020157013039A patent/KR20150072444A/ko not_active Withdrawn
- 2013-10-15 AU AU2013333975A patent/AU2013333975A1/en not_active Abandoned
- 2013-10-15 KR KR1020157013037A patent/KR20150058571A/ko not_active Withdrawn
- 2013-10-15 EA EA201590490A patent/EA201590490A1/ru unknown
- 2013-10-15 JP JP2015537216A patent/JP6236086B2/ja active Active
- 2013-10-15 WO PCT/EP2013/071472 patent/WO2014060383A1/en not_active Ceased
- 2013-10-15 EP EP13779191.9A patent/EP2908856B1/en active Active
- 2013-10-15 WO PCT/EP2013/071483 patent/WO2014060389A2/en not_active Ceased
- 2013-10-15 EP EP13779190.1A patent/EP2908855B1/en active Active
- 2013-10-15 JP JP2015537220A patent/JP2015534964A/ja active Pending
2015
- 2015-03-31 IL IL238053A patent/IL238053A0/en unknown
- 2015-04-01 IL IL238079A patent/IL238079A0/en unknown

Also Published As

Publication number	Publication date
CN104853768A (zh)	2015-08-19
EP2908854A2 (en)	2015-08-26
MX365842B (es)	2019-06-17
JP2015534962A (ja)	2015-12-07
EA201590490A1 (ru)	2015-10-30
CN104968366B (zh)	2017-12-01
WO2014060389A3 (en)	2014-09-12
SG11201502635SA (en)	2015-05-28
EP2908855B1 (en)	2017-06-28
JP6236086B2 (ja)	2017-11-22
AU2013331781A8 (en)	2015-05-14
WO2014060385A1 (en)	2014-04-24
IL238079A0 (en)	2015-05-31
JP2015534964A (ja)	2015-12-07
CA2888300A1 (en)	2014-04-24
KR20150058571A (ko)	2015-05-28
EA201590491A1 (ru)	2016-01-29
WO2014060383A1 (en)	2014-04-24
CA2888310C (en)	2021-07-06
JP2015536312A (ja)	2015-12-21
BR112015008418A2 (pt)	2017-07-04
EP2908856A1 (en)	2015-08-26
CA2888321A1 (en)	2014-04-24
BR112015008419A8 (pt)	2019-09-10
CN104968366A (zh)	2015-10-07
EP2908855A1 (en)	2015-08-26
BR112015008419A2 (pt)	2017-07-04
MX2015004949A (es)	2015-07-06
JP6412500B2 (ja)	2018-10-24
KR20150072444A (ko)	2015-06-29
BR112015008419B1 (pt)	2022-11-08
ES2640320T3 (es)	2017-11-02
MX2015005002A (es)	2015-07-17
CA2888310A1 (en)	2014-04-24
CN104853768B (zh)	2019-04-19
AU2013331781A1 (en)	2015-05-07
BR112015008417A8 (pt)	2019-09-10
SG11201502634TA (en)	2015-05-28
AU2013333975A1 (en)	2015-05-07
WO2014060389A2 (en)	2014-04-24
BR112015008417A2 (pt)	2017-07-04
EP2908856B1 (en)	2019-02-20

Publication	Publication Date	Title
IL238053A0 (en)	2015-05-31	An immunogenic composition containing one or more conjugates of capsular saccharide of Streptococcus pneumoniae and a protein component containing protein e and/or pila of Haemophilus influenzae
SI2167121T1 (sl)	2015-12-31	Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
IL283554A (en)	2021-07-29	Capsular polysaccharides of Streptococcus pneumoniae and their conjugates
LT1973564T (lt)	2016-12-27	Vakcina, apimanti streptococcus pneumoniae kapsulinio polisacharido konjugatus
IL221283A0 (en)	2012-10-31	15-valent pneumococcal polysaccharide - protein conjugate vaccine composition
SG10201403702SA (en)	2014-09-26	Vaccines and compositions against streptococcus pneumoniae
IL246738A0 (en)	2016-08-31	Capsular polysaccharides of Streptococcus pneumoniae and their conjugates
AP2010005173A0 (en)	2010-02-28	Compositions comprising pneumococcal antigens
ZA201206504B (en)	2016-06-29	Immunogenic composition comprising s. pneumoniae polysaccharides conjugates to carrier proteins
SG10201600435UA (en)	2016-02-26	Vaccines And Compositions Against Streptococcus Pneumoniae
EP2593467A4 (en)	2014-03-12	ANTICANCER VACCINES AND ANTIBODY-BASED MEDICINES BASED ON GLUCIDIC HAPTENES
ZA200805409B (en)	2012-09-26	Vaccine comprising streptococcus pneumoniae capsular polyaccharide conjugates
HK1172562A (en)	2013-05-31	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
AU2013360597B2 (en)	2016-03-31	Multivalent pneumococcal polysaccharide-protein conjugate composition
HK1122502A (en)	2009-05-22	Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates